B. Douglas Smith

2.7k citations

23 papers · 1.6k indexed · 1 hit paper · h-index 13

Impact in

Hematology top 1%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
Oncology top 5%
- Cancer Cells and Metastasis

Papers in

Hematology 19
- Acute Myeloid Leukemia Research 12
- Chronic Myeloid Leukemia Treatments 7
- Hematopoietic Stem Cell Transplantation 3
Genetics 6
- Chronic Lymphocytic Leukemia Research 6

Co-authors: Richard J. Jones William Matsui Carol Ann Huff James Barber Qiuju Wang Yvette C. Tanhehco Matthew Malehorn Curt I. Civin
Journals: Blood (8 papers)British Journal of Haematology (2 papers)Leukemia Research (2 papers)Cancer Research (2 papers)Journal of Clinical Oncology (1 paper)
Partner nations: United States United Kingdom Spain

In The Last Decade

B. Douglas Smith

21 papers receiving 1.6k citations

Hit Papers

align trajectories log scale

Characterization of clonogenic multiple myeloma cells 2003 · 600 citations

Peers

Countries citing papers authored by B. Douglas Smith

Since Specialization

Citations

This map shows the geographic impact of B. Douglas Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Douglas Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Douglas Smith more than expected).

Fields of papers citing papers by B. Douglas Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Douglas Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Douglas Smith. The network helps show where B. Douglas Smith may publish in the future.

Co-authors

The 25 scholars most cited alongside B. Douglas Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with B. Douglas Smith Line = papers co-authored together B. Douglas Smith links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Infections in secondary immunodeficiency patients treated with Privigen^®or Hizentra^®: a retrospective US administrative claims study in patients with hematological malignancies Leukemia & lymphoma ·Rajiv Mallick, Victoria Divino, B. Douglas Smith, Stephen Jolles, Mitch DeKoven, Donald C. Vinh	2021	10
2	Risk factors for severe infections in secondary immunodeficiency: a retrospective US administrative claims study in patients with hematological malignancies Leukemia & lymphoma ·Stephen Jolles, B. Douglas Smith, Donald C. Vinh, Rajiv Mallick, Gabriela M. Espinoza, Mitch DeKoven, Victoria Divino	2021	13
3	Expression of putative leukemia stem cell targets in genetically-defined acute myeloid leukemia subtypes Leukemia Research ·Breann Yanagisawa, Brandy Perkins, Theodoros Karantanos, Mark J. Levis, Gabriel Ghiaur, B. Douglas Smith, Richard J. Jones	2020	11
4	Zella 201: A Biomarker-Guided Phase II Study of Alvocidib Followed By Cytarabine and Mitoxantrone in MCL-1 Dependent Acute Myeloid Leukemia (AML): Results of Newly Diagnosed High-Risk Exploratory Arm Blood ·Joshua F. Zeidner, Daniel J. Lee, Gil D. Fine, Eunice S. Wang, Vijaya Raj Bhatt, Andrew Dalovisio, Pau Montesinos, Kathryn S. Kolibaba, Stephen P. Anthony, David J. Bearss, B. Douglas Smith	2020	0
5	Translating leukemia stem cells into the clinical setting: Harmonizing the heterogeneity Experimental Hematology ·Breann Yanagisawa, Gabriel Ghiaur, B. Douglas Smith, Richard J. Jones	2016	17
6	Association of acute myeloid leukemias most immature phenotype with risk groups and outcomes Haematologica ·Jonathan M. Gerber, Joshua F. Zeidner, Stephen S. Morse, Amanda L. Blackford, Bradley A. Perkins, Breann Yanagisawa, Hui Zhang, Laura Morsberger, Judith E. Karp, Yi Ning, Christopher D. Gocke, Gary L. Rosner, B. Douglas Smith, Richard J. Jones	2016	19
7	Assessment of Drug Sensitivity in Hematopoietic Stem and Progenitor Cells from Acute Myelogenous Leukemia and Myelodysplastic Syndrome Ex Vivo Stem Cells Translational Medicine ·Katherine Knorr, Laura Finn, B. Douglas Smith, Allan D. Hess, James M. Foran, Judith E. Karp, Scott H. Kaufmann	2016	7
8	Abnormal erythrocyte endothelial adherence in ischemic heart disease Clinical Hemorheology and Microcirculation ·B. Douglas Smith, Jemesha Thomas, John A. Gillespie	2016	0
9	Granulocyte-macrophage colony stimulating factor (GM-CSF) enhances the clinical responses to interferon-α (IFN) in newly diagnosed chronic myeloid leukemia (CML) Leukemia Research ·Joshua F. Zeidner, Douglas E. Gladstone, Marianna Zahurak, William Matsui, Christopher D. Gocke, Richard J. Jones, B. Douglas Smith	2014	7
10	CXCR4 Chemokine Receptor Signaling Induces Apoptosis in Acute Myeloid Leukemia Cells via Regulation of the Bcl-2 Family Members Bcl-XL, Noxa, and Bak Journal of Biological Chemistry ·Kimberly N. Kremer, Kevin L. Peterson, Paula A. Schneider, X. Wei Meng, Haiming Dai, Allan D. Hess, B. Douglas Smith, Christie Rodriguez-Ramirez, Judith E. Karp, Scott H. Kaufmann, Karen E. Hedin	2013	57
11	A clinically relevant population of leukemic CD34+CD38− cells in acute myeloid leukemia Blood ·Jonathan M. Gerber, B. Douglas Smith, Brownhilda Ngwang, Hao Zhang, Milada S. Vala, Laura Morsberger, Steven Galkin, Michael I. Collector, Brandy Perkins, Mark J. Levis, Constance A. Griffin, Saul J. Sharkis, Michael J. Borowitz, Judith E. Karp, Richard J. Jones	2012	175
12	The Clinical Relevance of Acute Myeloid Leukemia Stem Cells Blood ·Jonathan M. Gerber, B. Douglas Smith, Brownhilda Ngwang, Hao Zhang, Milada S. Vala, Laura Morsberger, Steven Galkin, Michael Collector, Brandy Perkins, Mark J. Levis, Constance A. Griffin, Saul J. Sharkis, Michael J. Borowitz, Judith E. Karp, Richard J. Jones	2011	3
13	Characterization of chronic myeloid leukemia stem cells American Journal of Hematology ·Jonathan M. Gerber, Qin Lu, Jeanne Kowalski, B. Douglas Smith, Constance A. Griffin, Milada S. Vala, Michael I. Collector, Brandy Perkins, Marianna Zahurak, William Matsui, Christopher D. Gocke, Saul J. Sharkis, Hyam I. Levitsky, Richard J. Jones	2010	69
14	Clonogenic Multiple Myeloma Progenitors, Stem Cell Properties, and Drug Resistance Cancer Research ·William Matsui, Qiuju Wang, James Barber, Sarah Brennan, B. Douglas Smith, Ivan Borrello, Ian McNiece, Lan Lin, Richard F. Ambinder, Craig D. Peacock, D. Neil Watkins, Carol Ann Huff, Richard J. Jones	2008	409
15	A phase 1 clinical-laboratory study of clofarabine followed by cyclophosphamide for adults with refractory acute leukemias Blood ·Judith E. Karp, Rebecca M. Ricklis, Kumudha Balakrishnan, Janet Briel, Jacqueline M. Greer, Steven D. Gore, B. Douglas Smith, Michael A. McDevitt, Hetty E. Carraway, Mark J. Levis, Varsha Gandhi	2007	59
16	Combined Methyltransferase/Histone Deacetylase Inhibition with 5-Azacitidine and MS-275 in Patients with MDS, CMMoL and AML: Clinical Response, Histone Acetylation and DNA Damage. Blood ·Steven D. Gore, Anchalee Jiemjit, Lewis B. Silverman, Timothy Aucott, Stephen B. Baylin, Hetty E. Carraway, Tianna Dauses, Tamer E. Fandy, James G. Herman, Judith E. Karp, Jonathan D. Licht, Anthony J. Murgo, Rosalie Odchimar-Reissig, B. Douglas Smith, James A. Zwiebel, Elizabeth A. Sugar	2006	26
17	Effects of imatinib and interferon on primitive chronic myeloid leukaemia progenitors British Journal of Haematology ·Greg R. Angstreich, William Matsui, Carol Ann Huff, Milada S. Vala, James Barber, Anita L. Hawkins, Constance A. Griffin, B. Douglas Smith, Richard J. Jones	2005	71
18	Requirement for myeloid growth factors in the differentiation of acute promyelocytic leukaemia British Journal of Haematology ·William Matsui, B. Douglas Smith, Milada S. Vala, Nikeshia Beal, Carol Ann Huff, Louis F. Diehl, Richard J. Jones	2005	18
19	K562/GM-CSF Vaccination Reduces Tumor Burden, Including Achieving Molecular Remissions, in Chronic Myeloid Leukemia (CML) Patients with Residual Disease on Imatinib Mesylate (IM). Blood ·B. Douglas Smith, Yvette L. Kasamon, Carole B. Miller, Christina Y. Chia, Kathleen M. Murphy, Jeanne Kowalski, Irena Tartakovsky, Barbara Biedrzycki, Richard J. Jones, Kristen Hege, Hyam I. Levitsky	2005	2
20	Chronic Myeloid Leukemia Stem Cells and Their Differentiated Progeny Display Divergent Drug Sensitivities to Imatinib Mesylate and Interferon-Alpha. Blood ·William Matsui, Greg R. Angstreich, Milada S. Vala, James Barber, Anita L. Hawkins, Constance A. Griffin, Carol Ann Huff, B. Douglas Smith, Richard J. Jones	2004	1

About B. Douglas Smith

B. Douglas Smith is a scholar working on Hematology, Genetics, Immunology, Public Health, Environmental and Occupational Health and Rheumatology, having authored 23 papers that have together received 1.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (12 papers), Acute Lymphoblastic Leukemia research (8 papers), Chronic Myeloid Leukemia Treatments (7 papers), Chronic Lymphocytic Leukemia Research (6 papers), Hematopoietic Stem Cell Transplantation (3 papers), Eosinophilic Disorders and Syndromes (3 papers), Phagocytosis and Immune Regulation (2 papers) and Pneumocystis jirovecii pneumonia detection and treatment (2 papers). The work is most often cited by research in Hematology (834 citations), Oncology (776 citations), Genetics (183 citations), Cancer Research (214 citations) and Immunology (285 citations). B. Douglas Smith has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Richard J. Jones, William Matsui, Carol Ann Huff, James Barber, Qiuju Wang, Yvette C. Tanhehco, Matthew Malehorn, Curt I. Civin, Ivan Borrello and D. Neil Watkins. Their work appears in journals such as Blood, British Journal of Haematology, Leukemia Research, Cancer Research and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact